Xylem (NYSE: XYL) EVP receives equity grants and withholds shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Xylem Inc. EVP and CPSO Claudia S. Toussaint reported equity compensation grants and related tax withholdings. On March 2, 2026, she received 7,089 non-qualified stock options with an exercise price of $128.98 per share, scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
She also acquired multiple blocks of common stock upon vesting of performance-based and ESG-related stock units granted in 2021 and 2023 under the Xylem 2011 Omnibus Incentive Plan, and received an additional restricted stock unit award set to vest in three annual tranches beginning March 1, 2027. To cover tax liabilities from these vestings, she disposed of several small blocks of common stock through share withholding at $128.98 per share. Following these transactions, she directly owns 9,342 shares of common stock, and an additional 31,250 shares are held indirectly by the Claudia S. Toussaint Revocable Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Toussaint Claudia S
Role
EVP, CPSO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Options (Right to Buy) | 7,089 | $128.98 | $914K |
| Grant/Award | Common Stock | 1,989 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,580 | $128.98 | $333K |
| Tax Withholding | Common Stock | 797 | $128.98 | $103K |
| Tax Withholding | Common Stock | 602 | $128.98 | $78K |
| Grant/Award | Common Stock | 2,360 | $128.98 | $304K |
| Grant/Award | Common Stock | 1,948 | $128.98 | $251K |
| Grant/Award | Common Stock | 1,324 | $128.98 | $171K |
| Grant/Award | Common Stock | 1,761 | $128.98 | $227K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Options (Right to Buy) — 7,089 shares (Direct);
Common Stock — 13,321 shares (Direct);
Common Stock — 31,250 shares (Indirect, by Claudia S. Toussaint Revocable Trust)
Footnotes (1)
- Reflects the acquisition of 2,360 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Reflects the acquisition of 1,948 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Reflects the acquisition of 1,324 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (336) and March 1, 2024 (266) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
FAQ
What equity awards did Xylem (XYL) EVP Claudia Toussaint receive?
Claudia Toussaint received new stock options and stock awards. She was granted 7,089 non-qualified stock options at $128.98 and multiple common-share awards tied to performance and ESG criteria under Xylem’s 2011 Omnibus Incentive Plan, plus a new restricted stock unit grant vesting from 2027 to 2029.
How many Xylem (XYL) stock options were granted to Claudia Toussaint?
She was granted 7,089 non-qualified stock options at an exercise price of $128.98 per share. These options vest in three equal annual installments on March 1, 2027, March 1, 2028, and March 1, 2029 under the Xylem 2011 Omnibus Incentive Plan.
What performance metrics triggered Claudia Toussaint’s Xylem (XYL) stock unit vesting?
The vesting was tied to several performance criteria. These included Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance, based on performance-based stock units granted in 2021 and 2023 under the Xylem 2011 Omnibus Incentive Plan.
When will Claudia Toussaint’s new Xylem (XYL) restricted stock units vest?
The new restricted stock units vest in three equal annual tranches. They are scheduled to vest one-third on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029, subject to the plan’s terms.